Oncolytics Biotech Inc.

    Oncolytics Biotech Inc.

    TTSX:ONC
    - -
    CAD
    - -
    - -
    Oncolytics Biotech Inc.
    TSX:ONC
    (Toronto Stock Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    CAD
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    -3.14
    -3.75
    -3.89
    -4.54
    -2.68
    -2.01
    -1.16
    -1.2
    -1.12
    -1.06
    -1.5
    -0.56
    -0.49
    -0.43
    -0.41
    -0.41
    -0.36
    Basic EPS, GAAP
    -3.1
    -2.74
    -3.05
    -4.29
    -2.81
    -2.14
    -1.28
    -0.99
    -1.08
    -0.75
    -0.9
    -0.55
    -0.42
    -0.4
    -0.42
    -0.36
    -0.29
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -22.94
    -21.1
    0.78
    -1.21
    -0.31
    -1.33
    -0.2
    -1.31
    -1.63
    -1.64
    -1.51
    -0.26
    -0.04
    -0.24
    -0.22
    -0.52
    -0.47
    Book Value per Share
    6.06
    6.38
    3.95
    1.85
    2.53
    1.49
    2.08
    0.85
    0.59
    0.39
    - -
    0.61
    0.67
    0.46
    0.41
    0.08
    0.07
    Tangible Book Value per Share
    5
    7
    7
    8
    9
    9
    12
    13
    14
    16
    22
    40
    54
    58
    68
    76
    84
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    -16
    -25
    -29
    -36
    -24
    -19
    -14
    -15
    -16
    -17
    -33
    -23
    -26
    -25
    -28
    -32
    -30
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    30
    41
    29
    14
    22
    13
    24
    10
    13
    12
    6
    31
    42
    32
    34
    12
    12
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    LT Debt
    31
    42
    30
    15
    22
    14
    25
    11
    8
    6
    - -
    25
    36
    27
    28
    6
    6
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    1
    1
    1
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    80
    86
    97
    Market Capitalization
    101
    63
    88

    Working Capital

    CAD

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    19
    18
    19
    Cash, Cash Equivalents & STI
    16
    15
    15
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    7
    6
    7
    Payables & Accruals
    5
    5
    5
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -2,322.46%
    -4,619.4%
    -78.29%
    Free Cash Flow
    5.86%
    6.79%
    -4.4%
    Net Income, GAAP
    9.59%
    1.05%
    14.26%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.1
    -0.12
    -0.14
    - -
    -0.41
    2024
    -0.09
    -0.1
    -0.12
    - -
    -0.41
    2025
    -0.08
    -0.07
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business